NASHVILLE, Tenn. & SAN CARLOS, Calif.–(BUSINESS WIRE)—- $ONC #BeOne–CLL Society, a leading authority for chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) patients, and BeOne Medicines, a global oncology company, today announced an expanded, multi-year partnership focused on strengthening education, engagement, and access to trusted resources across the CLL/SLL community. John V. Oyler, Co-Founder, Chairman and CEO, BeOne Medicines, said: “No two individuals with CLL or SLL are the sa

Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.